Your browser version may not work well with NCBI's Web applications. More information here...
Items 1 - 20 of 2495
of 125Next
1:

Acromegaly, growth hormone and cancer risk.

Renehan AG, Brennan BM.

Best Pract Res Clin Endocrinol Metab. 2008 Aug;22(4):639-57. Review.

PMID: 18971124 [PubMed - indexed for MEDLINE]

2:

[Pregnancy in active acromegaly]

Sahli R, Christ E.

Dtsch Med Wochenschr. 2008 Nov;133(45):2328-31. Epub 2008 Oct 28. German.

PMID: 18958828 [PubMed - indexed for MEDLINE]

3:

Unilateral atlantal mass hypertrophy in acromegaly. Case report.

Goel A, Shah AH, Menon R.

J Neurosurg Spine. 2008 Sep;9(3):277-80.

PMID: 18928225 [PubMed - indexed for MEDLINE]

4:

Insulin-mediated pseudoacromegaly: a case report and review of the literature.

Yaqub A, Yaqub N.

W V Med J. 2008 Sep-Oct;104(5):12-5. Review.

PMID: 18846753 [PubMed - indexed for MEDLINE]

5:

Gamma knife radiosurgery for acromegaly: outcomes after failed transsphenoidal surgery.

Jagannathan J, Sheehan JP, Pouratian N, Laws ER Jr, Steiner L, Vance ML.

Neurosurgery. 2008 Jun;62(6):1262-9; discussion 1269-70.

PMID: 18824992 [PubMed - indexed for MEDLINE]

6:

Gender dimorphism in body composition abnormalities in acromegaly: males are more affected than females.

Sucunza N, Barahona MJ, Resmini E, Fernández-Real JM, Farrerons J, Lluch P, Puig T, Wägner AM, Ricart W, Webb SM.

Eur J Endocrinol. 2008 Dec;159(6):773-9. Epub 2008 Sep 19.

PMID: 18805912 [PubMed - indexed for MEDLINE]

7:

Adrenal morpho-functional alterations in patients with acromegaly.

Scaroni C, Selice R, Benedini S, De Menis E, Arosio M, Ronchi C, Gasperi M, Manetti L, Arnaldi G, Polenta B, Boscaro M, Albiger N, Martino E, Mantero F.

J Endocrinol Invest. 2008 Jul;31(7):602-6.

PMID: 18787376 [PubMed - indexed for MEDLINE]

8:

Cardiac manifestations of GH deficiency after treatment for acromegaly: a comparison to patients with biochemical remission and controls.

van der Klaauw AA, Bax JJ, Bleeker GB, Holman ER, Delgado V, Smit JW, Romijn JA, Pereira AM.

Eur J Endocrinol. 2008 Dec;159(6):705-12. Epub 2008 Sep 11.

PMID: 18787048 [PubMed - indexed for MEDLINE]

9:

Additional metabolic effects of adding GH receptor antagonist to long-acting somatostatin analog in patients with active acromegaly.

Jawiarczyk A, Kałuzny M, Bolanowski M, Bednarek-Tupikowska G.

Neuro Endocrinol Lett. 2008 Aug;29(4):571-6.

PMID: 18766168 [PubMed - indexed for MEDLINE]

10:

Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease.

Davi' MV, Dalle Carbonare L, Giustina A, Ferrari M, Frigo A, Lo Cascio V, Francia G.

Eur J Endocrinol. 2008 Nov;159(5):533-40. Epub 2008 Sep 2.

PMID: 18765561 [PubMed - indexed for MEDLINE]

11:

Results of surgical and somatostatin analog therapies and their combination in acromegaly: a retrospective analysis of the German Acromegaly Register.

Petersenn S, Buchfelder M, Reincke M, Strasburger CM, Franz H, Lohmann R, Quabbe HJ, Plöckinger U; Participants of the German Acromegaly Register.

Eur J Endocrinol. 2008 Nov;159(5):525-32. Epub 2008 Aug 28.

PMID: 18755874 [PubMed - indexed for MEDLINE]

12:

An update on treatment strategies for acromegaly.

Katznelson L.

Expert Opin Pharmacother. 2008 Sep;9(13):2273-80. Review.

PMID: 18710352 [PubMed - indexed for MEDLINE]

13:

Follow-up of pituitary tumor volume in patients with acromegaly treated with pegvisomant in clinical trials.

Jimenez C, Burman P, Abs R, Clemmons DR, Drake WM, Hutson KR, Messig M, Thorner MO, Trainer PJ, Gagel RF.

Eur J Endocrinol. 2008 Nov;159(5):517-23. Epub 2008 Aug 15.

PMID: 18708436 [PubMed - indexed for MEDLINE]

14:

Clinical use of cabergoline as primary and adjunctive treatment for acromegaly.

Moyes VJ, Metcalfe KA, Drake WM.

Eur J Endocrinol. 2008 Nov;159(5):541-5. Epub 2008 Aug 15.

PMID: 18708434 [PubMed - indexed for MEDLINE]

15:

The influence of age on the GH-IGF1 axis in patients with acromegaly.

Tanimoto K, Hizuka N, Fukuda I, Takano K, Hanafusa T.

Eur J Endocrinol. 2008 Oct;159(4):375-9. Epub 2008 Jul 24.

PMID: 18653547 [PubMed - indexed for MEDLINE]

16:

Quality of life in acromegalic patients during long-term somatostatin analog treatment with and without pegvisomant.

Neggers SJ, van Aken MO, de Herder WW, Feelders RA, Janssen JA, Badia X, Webb SM, van der Lely AJ.

J Clin Endocrinol Metab. 2008 Oct;93(10):3853-9. Epub 2008 Jul 22.

PMID: 18647806 [PubMed - indexed for MEDLINE]

17:

[Advances in the treatment of acromegaly]

Krysiak R, Okopień B, Marek B.

Pol Merkur Lekarski. 2008 Jan;24(139):59-65. Review. Polish.

PMID: 18634256 [PubMed - indexed for MEDLINE]

18:

The pathology of the ulnar nerve in acromegaly.

Tagliafico A, Resmini E, Nizzo R, Derchi LE, Minuto F, Giusti M, Martinoli C, Ferone D.

Eur J Endocrinol. 2008 Oct;159(4):369-73. Epub 2008 Jul 16.

PMID: 18632873 [PubMed - indexed for MEDLINE]

19:

[Acromegaly--from myths to facts]

Kałuzny M, Bolanowski M.

Endokrynol Pol. 2008 May-Jun;59(3):242-4. Polish.

PMID: 18615400 [PubMed - indexed for MEDLINE]

20:

Lipodystrophy in patients with acromegaly receiving pegvisomant.

Bonert VS, Kennedy L, Petersenn S, Barkan A, Carmichael J, Melmed S.

J Clin Endocrinol Metab. 2008 Sep;93(9):3515-8. Epub 2008 Jul 8.

PMID: 18611977 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 2495
of 125Next